The Lancet Public Health Highlights Impact of Zika Contraception Access Network (Z-CAN) for Women in Puerto Rico

Read more

The Gilstrap OBGYN Fellowship

It was exciting to be a voice and advocate for women's healthcare and to make a difference in a much broader sense.

-Aliza Machefsky, MD
2020-2022 Gilstrap Fellow

I use the skills and connections I made through the Gilstrap Fellowship every day.

-Kate Miele, MD, MA
2019-2020 Gilstrap Fellow

History of the Fellowship

Larry Gilstrap, III, MD, served as Director of Evaluation and Executive Director of the American Board of Obstetrics and Gynecology (ABOG) for 10 years. The focus of his career was maternal-fetal medicine with a special emphasis on infectious diseases in women and in pregnancy. His passion is transforming clinical research into clinical practice improvements. He authored more than 200 peer-reviewed publications, more than 100 chapters and several major textbooks. When Dr. Gilstrap retired in 2017, ABOG partnered with the CDC Foundation and the Centers for Disease Control and Prevention (CDC) to establish this fellowship to honor his academic and public health career. In 2021, the CDC Foundation entered into a cooperative agreement with CDC to continue the fellowship.

About the Fellowship

The Gilstrap OBGYN Fellowship, open to recent obstetrics/gynecology residents and fellows within 5 years of graduation, places fellows within CDC in Atlanta, GA. Fellows will be integrated into the Division of STD Prevention (DSTDP), the Division of Reproductive Health (DRH) or the Division of Birth Defects and Infant Disorders (DBDID). Fellows will work closely with their mentors to develop a curriculum that meets their public health goals and will have the opportunity to conduct research and attend or present at various national conferences. At the completion of this fellowship, fellows will have a strong foundation in emerging public health concerns, maternal and fetal health with a focus on health equity, and public health surveillance systems. 

The Gilstrap fellowship is a one-year opportunity with the possibility of an extension for an additional year, pending on performance and interest. This is a non-clinical position, fellows are eligible and encouraged to participate in clinical activities with external clinical organizations if desired.

The Gilstrap Fellowship starts annually in August. Applicants are encouraged to apply up to a year and half in advance of their anticipated cohort start. The final deadline for applications for each fellowship cohort is March 15th of the same year however, the application will remain open to accommodate applicants for future years. When applying, please indicate your anticipated cohort (e.g., August 2023). Applications will be considered on a rolling basis, initial fellowship decisions will be available in early spring, and any unfilled positions will continue to be considered on a rolling basis.

Contact Sarah Morgan at smorgan@cdcfoundation.org for any questions.

To apply for the Gilstrap Fellowship, visit our recruitment page.


This project was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $592,543 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by CDC/HHS or the U.S. Government.

968
Image
ABOG
The Gilstrap OBGYN Fellowship
United States of America
To provide obstetricians and gynecologists with fellowship training opportunities in infectious diseases and sexually transmitted diseases in women and in pregnancy at the Centers for Disease Control and Prevention.
American Board of Obstetrics and Gynecology
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off

Vital Support for Zika Response Provided by Pfizer and Pfizer Foundation Contributions

To support efforts to stem the Zika outbreak, the CDC Foundation announced a $1 million donation from the Pfizer Foundation in funding for the comprehensive Zika response. Additionally, in-kind donations of up to 170,000 doses of injectable reversible contraceptive product from Pfizer have been provided for the Zika Contraception Access Network (Z-CAN) in Puerto Rico. In addition to donations of products and funding from multiple partners, this donation will provide essential support against this growing health threat for women who choose to delay or avoid pregnancy.

International Day of the Girl: Every Hour Matters

Read more

Preventing Zika-related Birth Defects Through Contraception Access

Read more

Comprehensive Zika Prevention Campaign Launches in Puerto Rico

A new communications campaign aimed at empowering pregnant women on how to prevent Zika virus transmission has launched in Puerto Rico. The campaign, part of an effort with the Centers for Disease Control and Prevention (CDC), the CDC Foundation, the Puerto Rico Department of Health and other partners announced in May, also focuses on empowering the social networks surrounding pregnant women—including partners, families, neighbors and community members—to take action to #StopZika in their homes and communities. 


Bayer Donations Help Provide Zika Protection for Women, Including Greater Access to Contraceptive Options and Improved Mosquito Control

In response to the growing Zika virus health threat, Bayer today committed to supporting two critical aspects of the Zika response in Puerto Rico: providing women and their partners who want to delay or avoid pregnancy during the Zika outbreak with improved access to a range of contraceptive methods and giving additional protection to families who want to sleep under mosquito-repelling bed nets. 

Subscribe to Women's Health